Related Experiment Video
Updated: Aug 5, 2025

Intratracheal Administration of Dry Powder Formulation in Mice
Published on: July 25, 2020
Design Considerations for Intratracheal Delivery Devices to Achieve Proof-of-Concept Dry Powder Biopharmaceutical
Myla Manser1, Vidthiya Jeyanathan2, Mangalakumari Jeyanathan2
1Department of Chemical Engineering, McMaster University, Hamilton, ON, L8S 4L7, Canada.
Optimizing dry powder inhaler devices for intratracheal vaccine delivery in mice is crucial. A polypropylene dosator achieved 50% in vivo delivery, maintaining viral vector bioactivity in lung tissue.
Area of Science:
- Pulmonary drug delivery
- Vaccine technology
- Biomedical engineering
Background:
- Intratracheal delivery of dry powder vaccines in mice presents significant challenges.
- Device design and actuation parameters critically influence powder flow and in vivo delivery efficacy.
Purpose of the Study:
- To assess the impact of positive pressure dosator design and actuation parameters on dry powder vaccine delivery in mice.
- To optimize device parameters for consistent and effective intratracheal administration of dry powder vaccines.
Main Methods:
- Evaluated chamber-loading dosators with various needle tips (stainless-steel, polypropylene, polytetrafluoroethylene).
- Compared powder loading methods (tamp-loading, chamber-loading, pipette tip-loading).
- Assessed in vivo emitted dose and bioactivity of spray-dried adenovirus in mouse lung tissue.
Main Results:
- A stainless-steel tip showed high initial powder availability (45%) but poor flexibility for mouse intubation.
- A polypropylene pipette tip-loading dosator, with optimized parameters, achieved 50% in vivo emitted dose.
- High bioactivity of the delivered viral-vectored dry powder vaccine was confirmed in mouse lung tissue.
Conclusions:
- Demonstrated successful intratracheal delivery of a viral-vectored dry powder vaccine in mice, achieving comparable bioactivity to liquid formulations.
- The optimized polypropylene dosator design provides a viable platform for murine intratracheal dry powder vaccine delivery.
- This research supports the advancement of inhalable therapeutics and dry powder vaccine development.
More Related Videos
04:59Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017